RT Journal Article
SR Electronic
T1 Quantifying the impacts of human mobility restriction on the spread of COVID-19: an empirical analysis from 344 cities of China
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.13.20148668
DO 10.1101/2020.07.13.20148668
A1 Tan, Jing
A1 Xiong, Yiquan
A1 Zhao, Shaoyang
A1 Liu, Chunrong
A1 Huang, Shiyao
A1 Lu, Xin
A1 Thabane, Lehana
A1 Xie, Feng
A1 Sun, Xin
A1 Li, Weimin
YR 2020
UL http://medrxiv.org/content/early/2020/07/15/2020.07.13.20148668.abstract
AB Objective Since the outbreak of novel coronavirus pneumonia (COVID-19), human mobility restriction measures have raised controversies, partly due to inconsistent findings. Empirical study is urgently needed to reliably assess the causal effects of mobility restriction.Methods Our study applied the difference-in-difference (DID) model to assess declines of population mobility at the city level, and used the log-log regression model to examine the effects of population mobility declines on the disease spread measured by cumulative or new cases of COVID-19 over time, after adjusting for confounders.Results The DID model showed that a continual expansion of the relative declines over time in 2020. After four weeks, population mobility declined by 54.81% (interquartile ranges, −65.50% to −43.56%). The accrued population mobility declines were associated with significant reduction of cumulative COVID-19 cases throughout six weeks (i.e., 1% decline of population mobility was associated with 0.72% (95%CI 0.50% to 0.93%) reduce of cumulative cases for one week, 1.42% two weeks, 1.69% three weeks, 1.72% four weeks,1.64% five weeks and 1.52% six weeks). The impact on weekly new cases seemed greater in the first four weeks, but faded thereafter. The effects on cumulative cases differed by cities of different population sizes, with greater effects seen in larger cities.Conclusion Persistent population mobility restrictions are well deserved. However, a change in the degree of mobility restriction may be warranted over time, particularly after several weeks of rigorous mobility restriction. Implementation of mobility restrictions in major cities with large population sizes may be even more important.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is not a clinical trial.Funding StatementThis work was supported by National Natural Science Foundation of China (71704122,71974138), and the National Science and Technology Major Project (2018ZX10302206), 1-3-5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYYC08003).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Review Board of West China Hospital, Sichuan University (2020-99)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data about population mobility, daily and cumulative COVID-19 cases at city level in mainland China, and outbound flow data from Wuhan to all other municipal cities during January 1, 2020 to January 22, 2020, may be available with the approval by the research team.